Pacira Biosciences (PCRX) - Stock price history

Stock price history of Pacira Biosciences from 2011 to 2025

Annual Stock Price Performance

Year	Performance
2025	41.19%
2024	-41.12%
2023	-13.18%
2022	-36.91%
2021	1.45%
2020	31.29%
2019	8.40%
2018	-7.08%
2017	31.37%
2016	-57.29%
2015	-15.84%
2014	56.86%
2013	230.78%
2012	100.11%
2011	23.22%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Recro Pharma REPH	A$3.16	-0.48%	🇺🇸 USA
Flexion Therapeutics FLXN	A$13.81	0.00%	🇺🇸 USA
Cara Therapeutics CARA	A$8.05	-2.56%	🇺🇸 USA
Heron Therapeutics HRTX	A$1.95	1.57%	🇺🇸 USA
Omeros Corporation OMER	A$13.87	3.74%	🇺🇸 USA
Zogenix ZGNX	A$40.39	0.00%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Pacira Biosciences (PCRX)